WANG Yan, YAN Wei. Prioritizing lung health: Achieving effective prevention and treatment of chronic obstructive pulmonary disease[J]. Chinese Journal of General Practice, 2025, 23(2): 194-197. doi: 10.16766/j.cnki.issn.1674-4152.003865
Citation: WANG Yan, YAN Wei. Prioritizing lung health: Achieving effective prevention and treatment of chronic obstructive pulmonary disease[J]. Chinese Journal of General Practice, 2025, 23(2): 194-197. doi: 10.16766/j.cnki.issn.1674-4152.003865

Prioritizing lung health: Achieving effective prevention and treatment of chronic obstructive pulmonary disease

doi: 10.16766/j.cnki.issn.1674-4152.003865
Funds:

 22QK18

  • Received Date: 2024-01-15
    Available Online: 2025-03-27
  • Chronic obstructive pulmonary disease (COPD) is the most common chronic respiratory disease. It is characterized by high incidence, disability, and mortality rates. It is considered to be one of the main causes of morbidity and mortality worldwidely. It contributes significantly to the economic and caregiving burdens on individuals, families, and society. The substantial burden of COPD has been widely recognized as a major global public health issue. However, the widespread lack of diagnosis and misdiagnosis lead to many patients either not receiving treatment or receiving inappropriate care, further complicating the prevention and control of COPD. Chronic obstructive pulmonary disease is a common, preventable, and treatable disease. It is currently believed that early detection, diagnosis, and intervention are crucial in the prevention and treatment of COPD, and can lead to significant improvements in public health. However, with the aging population and the increasing incidence of COPD in recent years, the current global diagnosis and treatment of COPD remains concerning. In China, public awareness of chronic obstructive pulmonary disease is low, and primary healthcare providers lack the necessary knowledge and prevention skills related to COPD. This significantly hampers the early, standardized prevention and treatment of COPD. This article discusses the current situation of prevention and treatment of chronic obstructive pulmonary disease in China and advocates for increased attention to lung health. Early screening, diagnosis, and intervention should be carried out for individuals with respiratory symptoms, such as chronic cough and shortness of breath, as well as high-risk factors for COPD. Timely referrals should be made, and in collaboration with respiratory specialists at tertiary hospitals, closed-loop management should be completed to established to ensure optimal lung health. The aim is to provide a framework for early prevention, diagnosis, and timely, appropriate treatment and intervention of COPD, ultimately opening new opportunities for improved care.

     

  • [1]
    Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease 2022 report[EB/OL]. (2021-11-15)[2022-04-18]. https://goldcopd.org/2022-gold-reports/.
    [2]
    陈典, 隆寰宇, 李姝润, 等. 2024年GOLD慢性阻塞性肺疾病诊断、治疗、管理及预防全球策略更新要点解读[J]. 中国全科医学, 2024, 27(13): 1533-1543. doi: 10.12114/j.issn.1007-9572.2023.0867

    CHEN D, LONG H Y, LI S R, et al. Interpretation of Global Strategy for the Diagnosis, Treatment, Management and Prevention of Chronic Obstructive Pulmonary Disease 2024 Report[J]. Chinese General Practice, 2024, 27(13): 1533-1543. doi: 10.12114/j.issn.1007-9572.2023.0867
    [3]
    GBD Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet Respir Med, 2020, 8(6): 585-596. doi: 10.1016/S2213-2600(20)30105-3
    [4]
    ADELOYE D, SONG P, ZHU Y, et al. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis[J]. Lancet Respir Med, 2022, 10(5): 447-458. doi: 10.1016/S2213-2600(21)00511-7
    [5]
    SAFIRI S, CARSON-CHAHHOUD K, NOORI M, et al. Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019[J]. BMJ, 2022, 378: e069679. DOI: 10.1136/bmj-2021-069679.
    [6]
    陈亚红. 2020年GOLD慢性阻塞性肺疾病诊断、治疗及预防全球策略解读[J]. 中国医学前沿杂志(电子版), 2019, 11(12): 32-50.

    CHEN Y H. Interpretation of global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2020 report[J]. Chinese Journal of the Frontiers of Medical Science(Electronic Version), 2019, 11(12): 32-50.
    [7]
    李香荷, 罗青, 唐娜, 等. 1990—2019年中国慢性阻塞性肺疾病死亡负担及变化情况分析[J]. 中国循环杂志, 2023, 38(6): 681-686.

    LI X H, LUO Q, TANG N, et al. Analysis of the Death Burden and Changes in Chronic Obstructive Pulmonary Disease in China from 1990 to 2019[J]. Chinese Journal of Circulation, 2023, 38(6): 681-686.
    [8]
    项文勤, 俞浩, 苏健, 等. 2015年与2019年江苏省40岁及以上人群慢性阻塞性肺疾病负担及吸烟归因疾病负担研究[J]. 中国慢性病预防与控制, 2022, 30(2): 81-86, 91.

    XIANG W Q, YU H, SU J, et al. Study on the Burden of Chronic Obstructive Pulmonary Disease and Smoking Attributed Disease Burden in People Aged 40 and Over in Jiangsu Province in 2015 and 2019[J]. China Chronic Disease Prevention and Control, 2022, 30(2): 81-86, 91.
    [9]
    LI H, LIANG H, WEI L, et al. Health inequality in the global burden of chronic obstructive pulmonary disease: findings from the Global Burden of Disease Study 2019[J]. Int J Chron Obstruct Pulmon Dis, 2022, 17: 1695-1702. doi: 10.2147/COPD.S369120
    [10]
    BURGE P S, CALVERLEY P M, JONES P W, et al. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial[J]. BMJ, 320(7245): 1297-303. DOI: 10.1136/bmj.320.7245.1297.
    [11]
    STOLBRINK M, THOMSON H, HADFIELD R M, et al. The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review[J]. Lancet Glob Health, 2022, 10(10): e1423-e1442. doi: 10.1016/S2214-109X(22)00330-8
    [12]
    陈康勰, 黄耀光, 李辉, 等. 常用血常规指标对慢性阻塞性肺疾病急性加重的诊断价值[J]. 中国全科医学, 2020, 23(13): 4.

    CHEN K X, HUANG Y G, LI H, et al. The diagnostic value of commonly used blood routine indicators for acute exacerbation of chronic obstructive pulmonary disease[J]. Chinese General Practice, 2020, 23(13): 4.
    [13]
    陈亚红. 慢性阻塞性肺疾病急性加重的风险识别与早期干预[J]. 中华全科医师杂志, 2019, 18(3): 296-298.

    CHEN Y H. Risk identification and early intervention for acute exacerbation of chronic obstructive pulmonary disease[J]. Chinese Journal of General Practitioners, 2019, 18(3): 296-298.
    [14]
    胡奕卿, 方继伟, 刘焕兵, 等. 肺功能检查技术如何在基层医疗卫生服务中更好地应用: 附重点问题专家解答[J]. 中国全科医学, 2023, 26(5): 532-536.

    HU Y Q, FANG J W, LIU H B, et al. How to better apply lung function testing technology in grassroots medical and health services-Expert answers to key questions[J]. Chinese General Practice, 2023, 26(5): 532-536.
    [15]
    彭博, 张小娟, 姜骁桐, 等. 基层医疗卫生机构慢性阻塞性肺疾病基本药物与诊断设备可获得性调查研究[J]. 中国全科医学, 2022, 25(7): 771-781.

    PENG B, ZHANG X J, JIANG X T, et al. A survey on the availability of essential drugs and diagnostic equipment for chronic obstructive pulmonary disease in primary healthcare institutions[J]. Chinese General Practice, 2022, 25(7): 771-781.
    [16]
    杨群娣, 苏秋云, 陈晓英, 等. 上海市社区卫生服务中心慢性阻塞性肺疾病防控能力分析[J]. 中华全科医学, 2023, 21(3): 442-444, 525. doi: 10.16766/j.cnki.issn.1674-4152.002903

    YANG Q D, SU Q Y, CHEN X Y, et al. Analysis of the Prevention and Control Capability of Chronic Obstructive Pulmonary Disease in Shanghai Community Health Service Center[J]. Chinese Journal of General Practice, 2023, 21(3): 442-444, 525. doi: 10.16766/j.cnki.issn.1674-4152.002903
    [17]
    李凡, 盛春风, 王欢英. 提高全科医生在慢性病早期诊断和管理中的地位和作用: 以慢性阻塞性肺疾病为例[J]. 中国全科医学, 2021, 24(9): 1044-1050.

    LI F, SHENG C F, WANG H Y. Enhancing the Position and Role of General Practitioners in Early Diagnosis and Management of Chronic Diseases: A Case Study of Chronic Obstructive Pulmonary Disease[J]. Chinese General Practice, 2021, 24(9): 1044-1050.
    [18]
    逄慧, 潘子涵, 迟春花. 我国基层医疗卫生机构慢性阻塞性肺疾病呼吸康复的实施现状及展望[J]. 中华结核和呼吸杂志, 2021, 44(9): 828-833.

    PANG H, PAN Z H, CHI C H. Implementation status and prospects of respiratory rehabilitation for chronic obstructive pulmonary disease in primary healthcare institutions in China[J]. Chinese Journal of Tuberculosis and Respiratory Diseases, 2021, 44(9): 828-833.
    [19]
    翟文爽, 蔡汉炯, 钱佳, 等. 慢性阻塞性肺疾病患者家庭模式肺康复依从性变异曲线研究[J]. 中华全科医学, 2023, 21(7): 1157-1160, 1183. doi: 10.16766/j.cnki.issn.1674-4152.003073

    ZHAI W S, CAI H J, QIAN J, et al. A study on the variation curve of family model pulmonary rehabilitation compliance in patients with chronic obstructive pulmonary disease[J]. Chinese Journal of General Practice, 2023, 21(7): 1157-1160, 1183. doi: 10.16766/j.cnki.issn.1674-4152.003073
    [20]
    高连军, 赵红梅. 2017年全国各级医疗机构医生对肺康复的认知及实施状况的调查[J]. 中华结核和呼吸杂志, 2019, 42(4): 275-278.

    GAO L J, ZHAO H M. A survey on the understanding and implementation of lung rehabilitation among doctors at all levels of medical institutions nationwide in 2017[J]. Chinese Journal of Tuberculosis and Respiratory Diseases, 2019, 42(4): 275-278.
    [21]
    郝兴亮, 丁菊英, 王莹莹, 等. 理论与实践结合培训对基层医师慢性阻塞性肺疾病认知的影响[J]. 中华全科医师杂志, 2022, 21(5): 477-481.

    HAO X L, DING J Y, WANG Y Y, et al. The impact of theoretical and practical training on the cognition of chronic obstructive pulmonary disease among grassroots physicians[J]. Chinese Journal of General Practitioners, 2022, 21(5): 477-481.
    [22]
    陈明敏, 叶康丽, 徐志杰, 等. 我国慢性阻塞性肺疾病社区管理现状与展望[J]. 中国全科医学, 2020, 23(3): 251-256.

    CHEN M M, YE K L, XU Z J, et al. Current Status and Prospects of Community Management of Chronic Obstructive Pulmonary Disease in China[J]. Chinese General Practice, 2020, 23(3): 251-256.
    [23]
    陈婧瑜, 林修全, 章叶发, 等. 福建省40岁及以上居民慢性阻塞性肺疾病认知现状分析[J]. 慢性病学杂志, 2019, 20(3): 347-350.

    CHEN J Y, LIN X Q, ZHANG Y F, et al. Analysis of cognitive status of chronic obstructive pulmonary disease among residents aged 40 and above in Fujian Province[J]. Journal of Chronic Diseases, 2019, 20(3): 347-350.
    [24]
    CELLI B R, SINGH D, VOGELMEIER C, et al. New perspectives on chronic obstructive pulmonary disease[J]. Int J Chron Obstruct Pulmon Dis, 2022, 17: 2127-2136.
    [25]
    裴士杰, 阎刚, 邵强. 错失早期诊断时间与慢性阻塞性肺疾病严重程度的关系[J]. 国际呼吸杂志, 2023, 43(2): 229-234.

    PEI S J, YAN G, SHAO Q. The relationship between missed early diagnosis time and the severity of chronic obstructive pulmonary disease[J]. International Journal of Respiration, 2023, 43(2): 229-234.
    [26]
    YAWN B P, MARTINEZ F J. Point: can screening for COPD improve outcomes? Yes[J]. Chest, 2020, 157(1): 7-9. http://www.sciencedirect.com/science/article/pii/S0012369219312516
    [27]
    吴建忠, 黄可, 雷洁萍, 等. "中国县域慢阻肺管理中心"项目慢性阻塞性肺疾病高危人群筛查及危险因素分析[J]. 国际呼吸杂志, 2022, 42(12): 917-921.

    WU J Z, HUANG K, LEI J P, et al. Screening and risk factor analysis of high-risk population for chronic obstructive pulmonary disease in the "China County Chronic Obstructive Pulmonary Disease Management Center" project[J]. International Journal of Respiration, 2022, 42(12): 917-921.
    [28]
    中华医学会呼吸病学分会慢性阻塞性肺疾病学组, 中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会. 慢性阻塞性肺疾病诊治指南(2021年修订版)[J]. 中华结核和呼吸杂志, 2021, 44(3): 170-205.

    Chronic Obstructive Pulmonary Disease Group of the Respiratory Branch of the Chinese Medical Association, Chronic Obstructive Pulmonary Disease Working Committee of the Respiratory Branch of the Chinese Medical Association. Diagnosis and Treatment Guidelines for Chronic Obstructive Pulmonary Disease (Revised in 2021)[J]. Chinese Journal of Tuberculosis and Respiratory Diseases, 2021, 44(3): 170-205.
    [29]
    王凤燕, 张冬莹, 梁振宇, 等. 面向全科医生的《慢性阻塞性肺疾病诊治指南(2021年修订版)》解读[J]. 中国全科医学, 2021, 24(29): 3660-3663, 3677.

    WANG F Y, ZHANG D Y, LIANG Z Y, et al. Interpretation of the Diagnosis and Treatment Guidelines for Chronic Obstructive Pulmonary Disease (2021 Revised Edition) for General Practitioners[J]. Chinese General Practice, 2021, 24(29): 3660-3663, 3677.
    [30]
    王熙龙, 梁振宇, 张海云, 等. 慢性阻塞性肺疾病防控新视角: 慢阻肺前期人群的多维度思考[J]. 国际呼吸杂志, 2023, 43(2): 150-154.

    WANG X L, LIANG Z Y, ZHANG H Y, et al. A New Perspective on the Prevention and Control of Chronic Obstructive Pulmonary Disease: Multidimensional Thinking of the Pre COPD Population[J]. International Journal of Respiration, 2023, 43(2): 150-154.
    [31]
    梁振宇, 王凤燕, 陈子正, 等. 2023年GOLD慢性阻塞性肺疾病诊断、管理及预防全球策略更新要点解读[J]. 中国全科医学, 2023, 26(11): 1287-1298.

    LIANG Z Y, WANG F Y, CHEN Z Z, et al. Interpretation of the Key Points of the Global Strategy Update for Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease by GOLD in 2023[J]. Chinese General Practice, 2023, 26(11): 1287-1298.
    [32]
    潘明鸣, 李燕明. 提高慢性阻塞性肺疾病患者疫苗接种率: 从临床医师做起[J]. 中华结核和呼吸杂志, 2022, 45(4): 335-338.

    PAN M M, LI Y M. Improving the vaccination rate of patients with chronic obstructive pulmonary disease: Starting from clinical physicians[J]. Chinese Journal of Tuberculosis and Respiratory Diseases, 2022, 45(4): 335-338.
    [33]
    吕梦轩, 祁祯楠, 迟春花. 基于可穿戴设备的智慧医疗对慢性阻塞性肺疾病管理的影响[J]. 中华全科医师杂志, 2022, 21(3): 213-218.

    LYU M X, QI Z N, CHI C H. The impact of smart healthcare based on wearable devices on the management of chronic obstructive pulmonary disease[J]. Chinese Journal of General Practitioners, 2022, 21(3): 213-218.
  • Relative Articles

    [1]XUE Jiali, LU Hongyan, YU Fang, JIANG Xirui, FENG Xiangkan. Perceived fatigue and coping experience in elderly patients with chronic obstructive pulmonary disease: A qualitative study[J]. Chinese Journal of General Practice, 2023, 21(5): 792-796. doi: 10.16766/j.cnki.issn.1674-4152.002985
    [2]LI Jiehong, JIANG Dingyuan, LIN Fang, HUANG Ke, LIU Yu, ZHAO Fan. Status of disease perception in patients with interstitial pulmonary disease and COPD[J]. Chinese Journal of General Practice, 2023, 21(10): 1689-1692. doi: 10.16766/j.cnki.issn.1674-4152.003202
    [3]PAN Li-na, XU Lei, MENG Nan-nan, CHENG Yu-ting. Effect of different proportions of enteral parenteral nutrition on patients with early-stage chronic obstructive pulmonary disease complicated with respiratory failure type Ⅱ[J]. Chinese Journal of General Practice, 2023, 21(2): 203-206. doi: 10.16766/j.cnki.issn.1674-4152.002845
    [4]YAN Fei-fei, XU Xu-dong, ZHANG Hai-bo, JI Ya-feng. Effects of Jianpi Tongluo Decoction on chronic obstructive pulmonary disease complicated with depression[J]. Chinese Journal of General Practice, 2022, 20(7): 1211-1214. doi: 10.16766/j.cnki.issn.1674-4152.002560
    [5]ZHANG Ye-na, ZHAO Wei-he, CHEN Jing-lu, DU Xue-kui, HUA Qi-feng, SUN Shou-zhong. Study on relation between CT three-dimensional reconstruction of diaphragm morphology and CAT score in patients with COPD[J]. Chinese Journal of General Practice, 2020, 18(2): 282-285. doi: 10.16766/j.cnki.issn.1674-4152.001226
    [6]WU Jia-ping, LU Xiao-ling. Risk factors analysis of pneumoconiosis complicated with chronic obstructive pulmonary disease[J]. Chinese Journal of General Practice, 2020, 18(8): 1310-1312. doi: 10.16766/j.cnki.issn.1674-4152.001494
    [7]WANG Yan-hong, YU Yi-hua. Application of intensive care in patients with acute exacerbation of chronic obstructive pulmonary disease complicated with type 2 respiratory failure[J]. Chinese Journal of General Practice, 2019, 17(2): 321-324. doi: 10.16766/j.cnki.issn.1674-4152.000672
    [8]QIAO Zhi-hao, LIU Chang, ZHANG Meng-ya. Effect of Tanreqing injection combined tiotropium on respiratory function of pneumoconiosis patients with stable COPD and its mechanism[J]. Chinese Journal of General Practice, 2019, 17(3): 409-412. doi: 10.16766/j.cnki.issn.1674-4152.000694
    [9]LOU Yan, WANG Xiao-yu, CHEN Min-hua. Efficacy of TCM modified Qinggan Runfei Decoction combined with Western Medicine for chronic obstructive pulmonary disease with pneumonia in patients with Qi-Yin Deficiency syndrome[J]. Chinese Journal of General Practice, 2018, 16(2): 243-246,263. doi: 10.16766/j.cnki.issn.1674-4152.000068
    [10]LI Yan-fang, FANG Ying, LI Qin, SHI Yan, WANG Shi-qiang. Risk factor analysis of COPD with pulmonary thromboembolism and its nursing countermeasures[J]. Chinese Journal of General Practice, 2018, 16(3): 492-493,506. doi: 10.16766/j.cnki.issn.1674-4152.000136
    [11]ZHU Yue-yan, ZHANG Xiao-qin, LI Ya-qing, CHEN Chun. Protection effect and mechanism of stem cell mobilization on pulmonary surfactant of COPD rats[J]. Chinese Journal of General Practice, 2018, 16(2): 176-179,183. doi: 10.16766/j.cnki.issn.1674-4152.000050
    [12]ZHOU Zhi-qiang, QU Jian-wei, XIAN Ben-song, QU Jian-hui, QU Jian-jiao. Meta-analysis of efficacy of pneumococcal vaccination in patients with chronic obstructive pulmonary disease[J]. Chinese Journal of General Practice, 2018, 16(9): 1562-1565,1574. doi: 10.16766/j.cnki.issn.1674-4152.000425
    [13]SHI Yan, FANG Ying, LI Yun-na, WANG Shi-qiang, LI Yan-fang, YIN Cui-ying. Risk factors analysis and nursing strategies of COPD patients with pulmonary fungal infection[J]. Chinese Journal of General Practice, 2018, 16(2): 309-312. doi: 10.16766/j.cnki.issn.1674-4152.000086
    [15]HU Ping, WANG Juan, ZHANG Yun-jian. Analysis of homocysteine and blood lipid levels in patients with chronic obstructive pulmonary disease[J]. Chinese Journal of General Practice, 2017, 15(10): 1711-1713,1751. doi: 10.16766/j.cnki.issn.1674-4152.2017.10.022
    [16]GUO Ya-nan, ZHANG Ting-ya, LIU Yun-feng. Application and effectiveness of dual track interactive nursing intervention of three subjects on elderly patients with COPD[J]. Chinese Journal of General Practice, 2017, 15(6): 1079-1082. doi: 10.16766/j.cnki.issn.1674-4152.2017.06.050
    [17]DONG Hong-ying, ZHANG Yun-xia. The prevalence rate and risk factors of venous thromboembolism in 239 cases with acute exacerbation chronic obstructive pulmonary disease[J]. Chinese Journal of General Practice, 2017, 15(1): 76-78. doi: 10.16766/j.cnki.issn.1674-4152.2017.01.024
    [18]CHEN Su-zhen, WANG Shi-qiang, HU Dan-dan, HUANG Li-sou, YANG Kai, ZHANG Hong, LOU Li-ming, HUANG Hui-xian, XU Yi-kai, ZHANG Qian. Analysis on characteristics of Chinese medicine constitution in COPD patients with depression[J]. Chinese Journal of General Practice, 2017, 15(3): 505-507. doi: 10.16766/j.cnki.issn.1674-4152.2017.03.043
    [19]CHEN Gang, XU Yong-fang, GU Xiao-min, ZHU Yong-ze. Relationship between serum MMP-9,TNF-α and bone turnover markers in male patients with stable chronic obstructive pulmonary disease[J]. Chinese Journal of General Practice, 2016, 14(6): 987-989. doi: 10.16766/j.cnki.issn.1674-4152.2016.06.034
    [20]LUO Xia-jie, YE Hong-bo, LU Yan-ping, YANG Jiang-ming. Correlation factors of obstructive sleep apnea hypopnea syndrome with chronic obstructive pulmonary disease[J]. Chinese Journal of General Practice, 2016, 14(3): 417-419. doi: 10.16766/j.cnki.issn.1674-4152.2016.03.027
  • Created with Highcharts 5.0.7Amount of accessChart context menuAbstract Views, HTML Views, PDF Downloads StatisticsAbstract ViewsHTML ViewsPDF Downloads2024-052024-062024-072024-082024-092024-102024-112024-122025-012025-022025-032025-0402468
    Created with Highcharts 5.0.7Chart context menuAccess Class DistributionFULLTEXT: 37.5 %FULLTEXT: 37.5 %META: 56.3 %META: 56.3 %PDF: 6.3 %PDF: 6.3 %FULLTEXTMETAPDF
    Created with Highcharts 5.0.7Chart context menuAccess Area Distribution十堰: 6.3 %十堰: 6.3 %厦门: 6.3 %厦门: 6.3 %合肥: 12.5 %合肥: 12.5 %哥伦布: 6.3 %哥伦布: 6.3 %成都: 6.3 %成都: 6.3 %武汉: 6.3 %武汉: 6.3 %芒廷维尤: 37.5 %芒廷维尤: 37.5 %襄阳: 6.3 %襄阳: 6.3 %诺沃克: 6.3 %诺沃克: 6.3 %长沙: 6.3 %长沙: 6.3 %十堰厦门合肥哥伦布成都武汉芒廷维尤襄阳诺沃克长沙

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (8) PDF downloads(1) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return